Yarlagadda S Babu Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yarlagadda S Babu.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yarlagadda S Babu. Yarlagadda S Babu is Senior VP - Drug Discovery in BIOCRYST PHARMACEUTICALS INC ($BCRX) and VP Drug Discovery in BIOCRYST PHARMACEUTICALS INC ($BCRX).
Yarlagadda S Babu in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yarlagadda S Babu: Senior VP - Drug Discovery, VP Drug Discovery
Holdings: 205,587 shares
Current Value: $1,165,678
Latest Transaction: Feb 23 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Yarlagadda S Babu in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 4.15 | 50,000 | 207,500 | 0 | |
| Feb 23 2021 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 11.53 | 22,431 | 258,629 | 183,156 | 205.6 K to 183.2 K (-10.91 %) |
| Feb 23 2021 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 4.15 | 50,000 | 207,500 | 205,587 | 155.6 K to 205.6 K (+32.14 %) |
| Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 8.31 | 280,000 | 2,326,800 | 280,000 | |
| Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Feb 25 2020 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 11.13 | 18,000 | 200,340 | 18,000 | |
| Feb 19 2020 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 11.13 | 31,500 | 350,595 | 31,500 | |
| Dec 19 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 3.23 | 225,000 | 726,750 | 225,000 | |
| Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | P | 1.45 | 25,000 | 36,250 | 155,587 | 130.6 K to 155.6 K (+19.14 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 1.20 | 12,188 | 14,626 | 0 | |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 1.20 | 19,686 | 23,623 | 0 | |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.68 | 1,685 | 14,626 | 130,587 | 132.3 K to 130.6 K (-1.27 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 1.20 | 12,188 | 14,626 | 132,272 | 120.1 K to 132.3 K (+10.15 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.68 | 7,702 | 66,853 | 120,084 | 127.8 K to 120.1 K (-6.03 %) |
| Feb 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 1.20 | 19,686 | 23,623 | 127,786 | 108.1 K to 127.8 K (+18.21 %) |
| Jan 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 8.07 | 771 | 6,222 | 108,100 | 108.9 K to 108.1 K (-0.71 %) |
| Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 7.06 | 235,000 | 1,659,100 | 235,000 | |
| Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 3.26 | 9,378 | 30,572 | 0 | |
| Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | M | 3.26 | 20,622 | 67,228 | 0 | |
| Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 5.18 | 5,902 | 30,572 | 108,871 | 114.8 K to 108.9 K (-5.14 %) |
| Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 3.26 | 9,378 | 30,572 | 114,773 | 105.4 K to 114.8 K (+8.90 %) |
| Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 5.18 | 15,223 | 78,855 | 105,395 | 120.6 K to 105.4 K (-12.62 %) |
| Mar 08 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Buy | M | 3.26 | 20,622 | 67,228 | 120,618 | 100 K to 120.6 K (+20.62 %) |
| Jan 23 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 5.59 | 3,872 | 21,644 | 99,996 | 103.9 K to 100 K (-3.73 %) |
| Jan 03 2018 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 4.91 | 838 | 4,115 | 103,868 | 104.7 K to 103.9 K (-0.80 %) |
| Dec 22 2017 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.04 | 100,000 | 504,000 | 100,000 | |
| Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 11.13 | 27,000 | 300,510 | 27,000 | |
| Mar 01 2017 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.51 | 175,000 | 964,250 | 175,000 | |
| Jan 24 2017 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 5.95 | 5,083 | 30,244 | 104,706 | 109.8 K to 104.7 K (-4.63 %) |
| Jan 03 2017 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 6.33 | 1,639 | 10,375 | 109,789 | 111.4 K to 109.8 K (-1.47 %) |
| Aug 29 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Sell | S | 4.06 | 30,000 | 121,800 | 111,428 | 141.4 K to 111.4 K (-21.21 %) |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 3.22 | 129,427 | 416,755 | 129,427 | |
| Mar 03 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 2.13 | 906 | 1,930 | 141,428 | 142.3 K to 141.4 K (-0.64 %) |
| Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 7.55 | 4,724 | 35,666 | 142,334 | 147.1 K to 142.3 K (-3.21 %) |
| Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 10.32 | 1,639 | 16,914 | 147,058 | 148.7 K to 147.1 K (-1.10 %) |
| Dec 31 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 10.82 | 62,573 | 677,040 | 62,573 | |
| Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
| Mar 20 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Sell | S | 10.16 | 12,105 | 122,987 | 148,697 | 160.8 K to 148.7 K (-7.53 %) |
| Mar 06 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Sell | S | 10.59 | 37,400 | 396,066 | 160,802 | 198.2 K to 160.8 K (-18.87 %) |
| Mar 05 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Sell | S | 10.50 | 10,495 | 110,198 | 198,202 | 208.7 K to 198.2 K (-5.03 %) |
| Mar 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Payment of Exercise | F | 10.20 | 1,634 | 16,667 | 208,697 | 210.3 K to 208.7 K (-0.78 %) |
| Mar 03 2011 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | A | 4.15 | 50,000 | 207,500 | 50,000 | |
| Mar 03 2011 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
| Mar 04 2010 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | A | 6.68 | 55,000 | 367,400 | 55,000 | |
| Jan 05 2010 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Payment of Exercise | F | 6.46 | 6,137 | 39,645 | 52,738 | 58.9 K to 52.7 K (-10.42 %) |
| Oct 28 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 10.85 | 6,400 | 69,422 | 39,362 | 45.8 K to 39.4 K (-13.99 %) |
| Oct 22 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 10.00 | 200 | 2,000 | 45,762 | 46 K to 45.8 K (-0.44 %) |
| Oct 21 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 10.00 | 3,400 | 34,000 | 45,962 | 49.4 K to 46 K (-6.89 %) |
| Sep 24 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Sell | S | 9.14 | 20,000 | 182,720 | 49,362 | 69.4 K to 49.4 K (-28.83 %) |
| Mar 04 2009 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | VP Drug Discovery | Option Exercise | A | 1.20 | 100,000 | 120,000 | 100,000 |
Page: 1